Faze Medicines Funding & Investors

Cambridge, MA

Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs.

Total Amount Raised: $81,000,000

Faze Medicines Funding Rounds

Series A
$81,000,000
Dec 9, 2020
Series A Investors
Third Rock Ventures
AbbVie Biotech Ventures
Alexandria Venture Investments
Novartis Venture Fund
Invus
Casdin Capital
Eli Lilly
Catalio Capital Management

Funding info provided by Diffbot.